0

12 Health Care Stocks Moving In Friday’s After-Market Session – Atossa Genetics (ATOS), Axsome Therapeutics (AXSM), ContraFect (CFRX), Enveric Biosciences, Inc. – Common Stock (ENVB), GRAPHITE CORP (GRPH)



Gainers

  • ContraFect (NASDAQ:CFRX) inventory moved upwards by 4.9% to $2.76 throughout Friday’s after-market session. The corporate’s market cap stands at $108.5 million.
  • Lexaria Bioscience (NASDAQ:LEXX) shares moved upwards by 4.76% to $4.51. The market worth of their excellent shares is at $26.8 million.
  • Atossa Therapeutics (NASDAQ:ATOS) shares moved upwards by 4.57% to $1.6. The corporate’s market cap stands at $202.5 million.
  • Enveric Biosciences (NASDAQ:ENVB) shares rose 4.42% to $0.9. The market worth of their excellent shares is at $29.4 million.
  • Axsome Therapeutics (NASDAQ:AXSM) shares moved upwards by 4.26% to $34.5. The market worth of their excellent shares is at $1.3 billion.
  • Quoin Prescription drugs (NASDAQ:QNRX) inventory moved upwards by 4.02% to $1.81. The corporate’s market cap stands at $15.1 million.

Losers

  • Graphite Bio (NASDAQ:GRPH) shares decreased by 6.2% to $10.4 throughout Friday’s after-market session. The market worth of their excellent shares is at $604.0 million.
  • Plus Therapeutics (NASDAQ:PSTV) shares declined by 6.07% to $1.24. On the shut, Plus Therapeutics’s buying and selling quantity reached 128.0K shares. That is 5.2% of its common quantity during the last 100 days. The corporate’s market cap stands at $19.0 million.
  • Ikena Oncology (NASDAQ:IKNA) inventory decreased by 5.43% to $11.5. The market worth of their excellent shares is at $412.9 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 5.27% to $4.5. Immediately’s buying and selling quantity for this safety ended up closing at 141.5K shares, which is 2.1 % of its common quantity during the last 100 days. The corporate’s market cap stands at $109.1 million.
  • China SXT Prescription drugs (NASDAQ:SXTC) inventory declined by 5.04% to $0.51. The corporate’s market cap stands at $7.8 million.
  • Reshape Lifesciences (NASDAQ:RSLS) inventory fell 5.04% to $1.51. The corporate’s market cap stands at $5.2 million.
    See Additionally: www.benzinga.com/cash/best-healthcare-stocks/

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.

admin

Leave a Reply

Your email address will not be published. Required fields are marked *